Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Karolinska Institutet
- University of Oslo
- Technical University of Denmark
- ;
- RMIT University
- University of Nottingham
- International PhD Programme (IPP) Mainz
- SciLifeLab
- The University of Iowa
- University of Antwerp
- ; University of Nottingham
- ; University of Southampton
- Duke University
- ETH Zurich
- ; University of East Anglia
- ; University of Sussex
- Heidelberg University
- The Netherlands Cancer Institute
- Trinity College Dublin
- University of Adelaide
- University of Basel
- University of Pittsburgh
- University of Utah
- Uppsala University
- ; Newcastle University
- AcademicTransfer
- Aix-Marseille Université
- Curtin University
- Ghent University
- International Institute of Molecular and Cell Biology in Warsaw
- Leibniz
- Leibniz Institute for Plasma Science and Technology
- Leiden University
- Luxembourg Institute of Health
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- Technical University of Munich
- The Ohio State University
- UNIVERSITY OF HELSINKI
- Umeå University
- University Medical Centre Groningen (UMCG)
- University of British Columbia
- University of Copenhagen
- ; University of Bradford
- ; University of Leeds
- ; University of Plymouth
- ; University of Surrey
- Amsterdam UMC
- Biobizkaia Health Research Institute
- Itä-Suomen yliopisto
- KTH Royal Institute of Technology
- KU Leuven
- KU Leuven (Coordinator)
- Monash University
- NORWEGIAN UNIVERSITY OF SCIENCE & TECHNOLOGY - NTNU
- NTNU Norwegian University of Science and Technology
- Rutgers University
- St. Anna Children's Cancer Research Institute (St. Anna CCRI)
- The University of Chicago
- University College Dublin
- University of Glasgow
- University of Houston
- University of Warsaw
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- Łukasiewicz Research Network – PORT Polish Center for Technology Development
- ; Berlin Institute of Health
- ; CRUK City of London Centre
- ; German Cancer Research Center (DKFZ)
- ; Leeds Beckett University
- ; Midlands Graduate School Doctoral Training Partnership
- ; Oxford Brookes University
- ; Swansea University
- ; The Open University
- ; The University of Edinburgh
- ; The University of Manchester
- ; University of Birmingham
- ; University of Hertfordshire
- ; University of Warwick
- AIT Austrian Institute of Technology
- AIT Austrian Institute of Technology GmbH
- AMOLF
- Aalborg University
- Academic Europe
- Baylor College of Medicine
- CNRS
- CNRS - Institut Fresnel
- CNRS CBMN UMR 5248
- Camden Cancer Research Center
- Campus Bio-Medico University
- Champalimaud Foundation
- Charles University in Prague, Faculty of Science
- DAAD
- Delft University of Technology
- Deutsches Krebsforschungszentrum
- ETH Zürich
- Emory University
- Erasmus MC (University Medical Center Rotterdam)
- ErasmusMC
- FUNDACION DE INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
- 90 more »
- « less
-
Field
-
exquisitely sensitive to the density of glycans expressed on the cell surface. If successful, these probes will be able to diagnose and target specific cell types, such as cancer cells, with exquisite
-
within a Research Infrastructure? No Offer Description Breast cancer is the most common cancer for women worldwide. Not all patients respond to chemotherapy for the necessary downstaging to permit breast
-
Skip to main content. Profile Sign Out View More Jobs PhD scholarship in Cancer Bioinformatics – DTU Health Tech Kgs. Lyngby, Denmark Job Description DTU Health Tech is seeking one PhD Student
-
drug discovery. The project will bridge two key stages in drug discovery to identify targets and ligands synergistically in unmet cancer therapeutic needs. Project Objectives DNA encoded libraries have
-
Primary supervisor - Dr Stephanie Schüller Colorectal cancer (CRC) is the third most common and second most fatal cancer globally. Most cases of CRC are not hereditary but influenced by lifestyle
-
25th April 2024 Languages English English English PhD Candidate in membrane dynamics and cancer cell invasion Apply for this job See advertisement Job description A 3-year position in a Research
-
Primary supervisor - Prof Daniel Brewer Background With an incidence of >1.4 million cases worldwide, prostate cancer is the most common non-skin cancer in men. One in eight men will obtain a
-
try again. 25th April 2024 Languages English English English PhD Candidate in membrane dynamics and cancer cell invasion Apply for this job See advertisement Job description A 3-year position in a
-
clinical potential of altered lipid metabolism in prostate cancer (PCa). Through its modular and bidirectional nature with multiple entry points, this pipeline is expected to generate outputs at multiple
-
to develop novel inhibitors for the treatment of advanced prostate cancer, one of the leading causes of male cancer deaths. Advanced prostate cancer that has metastasised to the bones and other tissues is very